Financial world news, market analysis, investment scam prevention tips and more ✔️ Learn all there is to know about the asset management industry. This magazine is crafted specifically for those who are interested in diving into the global asset management world. (RTTNews) - Shares of Moderna, Inc. (MRNA) are rising more than 16% Monday morning after the company said it is planning to apply for U.S and European Emergency approval of its Covid-19 vaccine mRNA-1273, as its late study showed that the vaccine candidate is 94.1% effective to prevent the disease. The stock touched a new high of $150 this morning The company on Monday said it plans to apply for Emergency Use Authorization (EUA) from the U.S. FDA and conditional approval from the European Medicines Agency (EMA). The company also reported vaccine efficacy against severe Covid-19 was 100%. To keep reading about Stock Alert: Moderna Jumps 16% As Covid Vaccine 94.1% Effective; To Apply For Emergency Use, Click on the link. Seo...
The gig economy is alive and well. Even as COVID-19 upended the typical workforce norms, with more employees gaining the flexibility to work remotely, millions are still choosing to find a way to go into business for themselves. According to the freelancing platform Upwork, 59 million Americans performed freelance work in 2020, with that number […] Seoul, Korea http://dlvr.it/SCpwSF
News, market analysis, investment scam prevention tips and more ✔️ Your source for latest asset management news and information. This magazine is crafted specifically for those who are interested in diving into the global asset management world. Indonesia gave Sinovac Biotech's Covid-19 vaccine its first emergency use approval outside China on Monday as the world's fourth most populous country launches nationwide inoculations to stem surging infections and deaths. To keep reading about Indonesia approves China's Sinovac vaccine as infections surge, Click on the link. Seoul, Korea http://dlvr.it/RqLHMP
Comments
Post a Comment